Clinical Trial Update: Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reporting on the efficacy and safety of Combigan and 0.5% Timoptic in normal tension glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Normal Tension Glaucoma

Drugs mentioned

• Combigan (brimonidine tartrate and timolol maleate)
• TIMOPTIC (timolol maleate)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Normal Tension Glaucoma | Phase 4 | Status: UNKNOWN